Artificial Nanoscale Erythrocytes from Clinically Relevant Compounds for Enhancing Cancer Immunotherapy

Because of enhanced efficacy and lower side effects, cancer immunotherapies have recently been extensively investigated in clinical trials to overcome the limitations of conventional cancer monotherapies. Although engineering attempts have been made to build nanosystems even including stimulus nanom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Wenquan, Nam, Kang Sik, Park, Dae Hoon, Hwang, Jungho, Ku, Sae Kwang, Yong, Chul Soon, Kim, Jong Oh, Byeon, Jeong Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770689/
https://www.ncbi.nlm.nih.gov/pubmed/34138119
http://dx.doi.org/10.1007/s40820-020-00428-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770689/
https://www.ncbi.nlm.nih.gov/pubmed/34138119
http://dx.doi.org/10.1007/s40820-020-00428-y

Ejemplares similares